Inventor
Daniel Elbaum
Inventor
Newton, MA, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds19%
C07KPeptides11%
Y02ATechnologies for adaptation to climate change11%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%
C04BLime, magnesia3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
11,014,965Modulation of complement activity202110,918,691Modulators of complement activity202110,588,936Modulators of complement activity202010,494,374Pyrrolopyrimidines as CFTR potentiators201910,435,438Modulation of complement activity201910,364,263Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders201910,328,115Modulators of complement activity201910,301,315Pyrrolopyrimidines as CFTR potentiators201910,272,132Peptide and peptidomimetic inhibitors201910,208,089Modulation of complement activity201910,106,579Modulation of complement activity20189,999,650Peptide and peptidomimetic inhibitors20189,937,222Modulators of complement activity20189,644,004'Peptide and peptidomimetic inhibitors'20179,428,522'Piperazines, pharmaceutical compositions and methods of use thereof'20169,238,676'Peptide and peptidomimetic inhibitors'20168,822,472'Piperazines, pharmaceutical compositions and methods of use thereof'20148,642,624'Substituted alkylamine derivatives and methods of use'20148,008,499'Anabaseine derivatives, pharmaceutical compositions and methods of use thereof'20117,989,498'Inhibitors of IMPDH enzyme'20117,943,622'Piperazines, pharmaceutical compositions and methods of use thereof'20117,662,965'Anabaseine derivatives, pharmaceutical compositions and method of use thereof'20107,531,553'Heterocyclic compounds and methods of use'20097,514,564'Substituted amine derivatives and methods of use'20097,442,698'Substituted heterocyclic compounds and methods of use'20087,320,992'Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use'20087,105,682'Substituted amine derivatives and methods of use'20067,102,009'Substituted amine derivatives and methods of use'20067,101,868'Substituted arylamine derivatives and methods of use'20067,074,789'Kinase inhibitors'20066,995,162'Substituted alkylamine derivatives and methods of use'20066,878,714'Substituted alkylamine derivatives and methods of use'20056,723,710'Compositions for inhibiting arginase activity'20046,653,309'Inhibitors of IMPDH enzyme technical field of the invention'20036,495,558'Kinase inhibitors'20026,387,890'Compositions and methods for inhibiting arginase activity'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2014Patents assigned to AMGEN INC (12)· patent assignee history
2002–2004Patents assigned to UNIV PENNSYLVANIA (2)· patent assignee history
2002–2021Based in Newton, MA, US· patent location history
2010–2016Patents assigned to CORNERSTONE THERAPEUTICS INC (5)· patent assignee history
2014Patents assigned to ELBAUM DANIEL (2)· patent assignee history
2016–2021Patents assigned to RA PHARMACEUTICALS INC (12)· patent assignee history
2019Based in Newman, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 12 | 2002–2014 |
| RA PHARMACEUTICALS INC | 12 | 2016–2021 |
| CORNERSTONE THERAPEUTICS INC | 5 | 2010–2016 |
| ELBAUM DANIELself | 2 | 2014 |
| UNIV PENNSYLVANIA | 2 | 2002–2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newton, Massachusetts, US | 34 | 2002–2021 |
| Newman, Massachusetts, US | 2 | 2019 |